共 50 条
- [41] Idecabtagene vicleucel for relapsed and refractory multiple myeloma: post hoc 18-month follow-up of a phase 1 trialNATURE MEDICINE, 2023, 29 (09) : 2286 - +Lin, Yi论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN 55902 USA Mayo Clin, Rochester, MN 55902 USARaje, Noopur S.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Canc Ctr, Harvard Med Sch, Boston, MA USA Mayo Clin, Rochester, MN 55902 USABerdeja, Jesus G.论文数: 0 引用数: 0 h-index: 0机构: Sarah Cannon Res Inst & Tennessee Oncol, Nashville, TN USA Mayo Clin, Rochester, MN 55902 USASiegel, David S.论文数: 0 引用数: 0 h-index: 0机构: Hackensack Univ, Med Ctr, Hackensack, NJ USA Mayo Clin, Rochester, MN 55902 USAJagannath, Sundar论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai Med Ctr, New York, NY USA Mayo Clin, Rochester, MN 55902 USAMadduri, Deepu论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai Med Ctr, New York, NY USA Mayo Clin, Rochester, MN 55902 USALiedtke, Michaela论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Med Ctr, Palo Alto, CA USA Mayo Clin, Rochester, MN 55902 USARosenblatt, Jacalyn论文数: 0 引用数: 0 h-index: 0机构: Beth Israel Deaconess Med Ctr, Boston, MA USA Mayo Clin, Rochester, MN 55902 USAMaus, Marcela V.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Canc Ctr, Harvard Med Sch, Boston, MA USA Mayo Clin, Rochester, MN 55902 USAMassaro, Monica论文数: 0 引用数: 0 h-index: 0机构: 2SeventyBio Inc, Cambridge, MA USA Mayo Clin, Rochester, MN 55902 USAPetrocca, Fabio论文数: 0 引用数: 0 h-index: 0机构: 2SeventyBio Inc, Cambridge, MA USA Mayo Clin, Rochester, MN 55902 USAYeri, Ashish论文数: 0 引用数: 0 h-index: 0机构: 2SeventyBio Inc, Cambridge, MA USA Mayo Clin, Rochester, MN 55902 USAFinney, Olivia论文数: 0 引用数: 0 h-index: 0机构: 2SeventyBio Inc, Cambridge, MA USA Mayo Clin, Rochester, MN 55902 USACaia, Andrea论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Mayo Clin, Rochester, MN 55902 USAYang, Zhihong论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Mayo Clin, Rochester, MN 55902 USAMartin, Nathan论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Mayo Clin, Rochester, MN 55902 USACampbell, Timothy B.论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Mayo Clin, Rochester, MN 55902 USARytlewski, Julie论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Mayo Clin, Rochester, MN 55902 USAFuller, Jaymes论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Mayo Clin, Rochester, MN 55902 USAHege, Kristen论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Mayo Clin, Rochester, MN 55902 USAMunshi, Nikhil C.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA USA Mayo Clin, Rochester, MN 55902 USAKochenderfer, James N.论文数: 0 引用数: 0 h-index: 0机构: NCI, NIH, Surg Branch, Bethesda, MD USA Mayo Clin, Rochester, MN 55902 USA
- [42] Phase 2 results of idecabtagene vicleucel (ide-cel, bb2121) in Japanese patients with relapsed and refractory multiple myelomaINTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 117 (05) : 729 - 737Minakata, Daisuke论文数: 0 引用数: 0 h-index: 0机构: Jichi Med Univ, Dept Med, Div Hematol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan Jichi Med Univ, Dept Med, Div Hematol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, JapanIshida, Tadao论文数: 0 引用数: 0 h-index: 0机构: Japanese Red Cross Med Ctr, Dept Hematol, Tokyo, Japan Jichi Med Univ, Dept Med, Div Hematol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, JapanAndo, Kiyoshi论文数: 0 引用数: 0 h-index: 0机构: Tokai Univ, Dept Hematol & Oncol, Sch Med, Isehara, Japan Jichi Med Univ, Dept Med, Div Hematol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, JapanSuzuki, Rikio论文数: 0 引用数: 0 h-index: 0机构: Tokai Univ, Dept Hematol & Oncol, Sch Med, Isehara, Japan Jichi Med Univ, Dept Med, Div Hematol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, JapanTanaka, Junji论文数: 0 引用数: 0 h-index: 0机构: Tokyo Womens Med Univ, Dept Hematol, Tokyo, Japan Univ Tsukuba, Fac Med, Ibaraki, Japan Jichi Med Univ, Dept Med, Div Hematol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, JapanHagiwara, Shotaro论文数: 0 引用数: 0 h-index: 0机构: Tokyo Womens Med Univ, Dept Hematol, Tokyo, Japan Univ Tsukuba, Fac Med, Ibaraki, Japan Jichi Med Univ, Dept Med, Div Hematol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, JapanAnanthakrishnan, Revathi论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Jichi Med Univ, Dept Med, Div Hematol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, JapanKuwayama, Shigeki论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb KK, Tokyo, Japan Jichi Med Univ, Dept Med, Div Hematol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, JapanNishio, Mitsufumi论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb KK, Tokyo, Japan Jichi Med Univ, Dept Med, Div Hematol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, JapanKanda, Yoshinobu论文数: 0 引用数: 0 h-index: 0机构: Jichi Med Univ, Dept Med, Div Hematol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan Jichi Med Univ, Dept Med, Div Hematol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, JapanSuzuki, Kenshi论文数: 0 引用数: 0 h-index: 0机构: Japanese Red Cross Med Ctr, Dept Hematol, Tokyo, Japan Jichi Med Univ, Dept Med, Div Hematol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan
- [43] Phase 2 results of idecabtagene vicleucel (ide-cel, bb2121) in Japanese patients with relapsed and refractory multiple myelomaInternational Journal of Hematology, 2023, 117 : 729 - 737Daisuke Minakata论文数: 0 引用数: 0 h-index: 0机构: Jichi Medical University,Division of Hematology, Department of MedicineTadao Ishida论文数: 0 引用数: 0 h-index: 0机构: Jichi Medical University,Division of Hematology, Department of MedicineKiyoshi Ando论文数: 0 引用数: 0 h-index: 0机构: Jichi Medical University,Division of Hematology, Department of MedicineRikio Suzuki论文数: 0 引用数: 0 h-index: 0机构: Jichi Medical University,Division of Hematology, Department of MedicineJunji Tanaka论文数: 0 引用数: 0 h-index: 0机构: Jichi Medical University,Division of Hematology, Department of MedicineShotaro Hagiwara论文数: 0 引用数: 0 h-index: 0机构: Jichi Medical University,Division of Hematology, Department of MedicineRevathi Ananthakrishnan论文数: 0 引用数: 0 h-index: 0机构: Jichi Medical University,Division of Hematology, Department of MedicineShigeki Kuwayama论文数: 0 引用数: 0 h-index: 0机构: Jichi Medical University,Division of Hematology, Department of MedicineMitsufumi Nishio论文数: 0 引用数: 0 h-index: 0机构: Jichi Medical University,Division of Hematology, Department of MedicineYoshinobu Kanda论文数: 0 引用数: 0 h-index: 0机构: Jichi Medical University,Division of Hematology, Department of MedicineKenshi Suzuki论文数: 0 引用数: 0 h-index: 0机构: Jichi Medical University,Division of Hematology, Department of Medicine
- [44] Idecabtagene Vicleucel Is Well Tolerated and Effective in Relapsed/ Refractory Myeloma Patients with Prior Allogeneic Stem Cell TransplantationTRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (10): : 609.e1 - 609.e6John, Lukas论文数: 0 引用数: 0 h-index: 0机构: Heidelberg Univ Hosp, Dept Internal Med 5, Heidelberg, Germany Univ Hosp Heidelberg, Dept Internal Med 5, Clin Cooperat Unit Mol Hematol Oncol, Heidelberg, Germany German Canc Res Ctr, Heidelberg, Germany Heidelberg Univ Hosp, Dept Internal Med 5, Heidelberg, GermanySauer, Sandra论文数: 0 引用数: 0 h-index: 0机构: Heidelberg Univ Hosp, Dept Internal Med 5, Heidelberg, Germany Heidelberg Univ Hosp, Dept Internal Med 5, Heidelberg, GermanyHegenbart, Ute论文数: 0 引用数: 0 h-index: 0机构: Heidelberg Univ Hosp, Dept Internal Med 5, Heidelberg, Germany Heidelberg Univ Hosp, Dept Internal Med 5, Heidelberg, GermanyDreger, Peter论文数: 0 引用数: 0 h-index: 0机构: Heidelberg Univ Hosp, Dept Internal Med 5, Heidelberg, Germany Heidelberg Univ Hosp, Dept Internal Med 5, Heidelberg, GermanyHundemer, Michael论文数: 0 引用数: 0 h-index: 0机构: Heidelberg Univ Hosp, Dept Internal Med 5, Heidelberg, Germany Heidelberg Univ Hosp, Dept Internal Med 5, Heidelberg, GermanyMueller-Tidow, Carsten论文数: 0 引用数: 0 h-index: 0机构: Heidelberg Univ Hosp, Dept Internal Med 5, Heidelberg, Germany Natl Ctr Tumor Dis, Heidelberg, Germany Heidelberg Univ Hosp, Dept Internal Med 5, Heidelberg, GermanySchmitt, Anita论文数: 0 引用数: 0 h-index: 0机构: Heidelberg Univ Hosp, Dept Internal Med 5, Heidelberg, Germany Heidelberg Univ Hosp, Dept Internal Med 5, Heidelberg, GermanySchmitt, Michael论文数: 0 引用数: 0 h-index: 0机构: Heidelberg Univ Hosp, Dept Internal Med 5, Heidelberg, Germany Heidelberg Univ Hosp, Dept Internal Med 5, Heidelberg, GermanyRaab, Marc S.论文数: 0 引用数: 0 h-index: 0机构: Heidelberg Univ Hosp, Dept Internal Med 5, Heidelberg, Germany Univ Hosp Heidelberg, Dept Internal Med 5, Clin Cooperat Unit Mol Hematol Oncol, Heidelberg, Germany German Canc Res Ctr, Heidelberg, Germany Heidelberg Univ Hosp, Dept Internal Med 5, Heidelberg, GermanySchoenland, Stefan O.论文数: 0 引用数: 0 h-index: 0机构: Heidelberg Univ Hosp, Dept Internal Med 5, Heidelberg, Germany Heidelberg Univ Hosp, Dept Internal Med 5, INF 410, Heidelberg, Germany Heidelberg Univ Hosp, Dept Internal Med 5, Heidelberg, Germany
- [45] Idecabtagene vicleucel chimeric antigen receptor T-cell therapy for relapsed and refractory multiple myeloma: real-world experienceCLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S2 - S3Hansen, Doris论文数: 0 引用数: 0 h-index: 0机构: H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA论文数: 引用数: h-index:机构:Peres, Lauren论文数: 0 引用数: 0 h-index: 0机构: H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USALeitzinger, Christelle Colin论文数: 0 引用数: 0 h-index: 0机构: H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USAShune, Leyla论文数: 0 引用数: 0 h-index: 0机构: Univ Kansas, Div Hematol Malignancies & Cellular Therapeut HMC, Med Ctr, Kansas City, KS USA H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USAShrewsbury, Alexandria论文数: 0 引用数: 0 h-index: 0机构: H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USAGonzalez, Rebecca论文数: 0 引用数: 0 h-index: 0机构: H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USASborov, Douglas论文数: 0 引用数: 0 h-index: 0机构: Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USAWagner, Charlotte论文数: 0 引用数: 0 h-index: 0机构: Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USAHashmi, Hamza论文数: 0 引用数: 0 h-index: 0机构: Med Univ South Carolina, Columbia, SC USA H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USAKocoglu, Mehmet论文数: 0 引用数: 0 h-index: 0机构: Univ Maryland, Med Ctr, College Pk, MD USA H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USAAtrash, Shebli论文数: 0 引用数: 0 h-index: 0机构: Atrium Hlth, Levine Canc Inst, Charlotte, NC USA H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USASimmons, Gary论文数: 0 引用数: 0 h-index: 0机构: Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23284 USA H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USAKalariya, Nilesh论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USA H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USAFerreri, Christopher论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USA H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USAAfrough, Aimaz论文数: 0 引用数: 0 h-index: 0机构: UT Southwestern Harold C Simmons Comprehens Canc, Dallas, TX USA H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USAKansagra, Ankit论文数: 0 引用数: 0 h-index: 0机构: UT Southwestern Harold C Simmons Comprehens Canc, Dallas, TX USA H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USAVoorhees, Peter论文数: 0 引用数: 0 h-index: 0机构: Atrium Hlth, Levine Canc Inst, Charlotte, NC USA H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USABaz, Rachid论文数: 0 引用数: 0 h-index: 0机构: H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USAKhouri, Jack论文数: 0 引用数: 0 h-index: 0机构: Cleveland Clin Fdn, Cleveland, OH USA H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USAAlsina, Melissa论文数: 0 引用数: 0 h-index: 0机构: H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplantat & Cellular Immun, Tampa, FL USA H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA论文数: 引用数: h-index:机构:Locke, Frederick论文数: 0 引用数: 0 h-index: 0机构: H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USAPatel, Krina论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX USA H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
- [46] Impact of extramedullary multiple myeloma on outcomes with idecabtagene vicleucel.JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)Zanwar, Saurabh论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Div Hematol, Rochester, MN USASidana, Surbhi论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Div Hematol, Rochester, MN USAShune, Leyla论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Div Hematol, Rochester, MN USAAlexis, Omar论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Div Hematol, Rochester, MN USAPuglianini, Castaneda论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Div Hematol, Rochester, MN USAPasvolsky, Oren论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Div Hematol, Rochester, MN USAGonzalez, Rebecca论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Div Hematol, Rochester, MN USADima, Danai论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Div Hematol, Rochester, MN USAAfrough, Aimaz论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Div Hematol, Rochester, MN USAKaur, Gurbakhash论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Div Hematol, Rochester, MN USADavis, James A.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Div Hematol, Rochester, MN USAHerr, Megan论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Div Hematol, Rochester, MN USAHashmi, Hamza论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Div Hematol, Rochester, MN USAForsberg, Peter A.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Div Hematol, Rochester, MN USASborov, Douglas W.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Div Hematol, Rochester, MN USARichard, Shambavi论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Div Hematol, Rochester, MN USAKhouri, Jack论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Div Hematol, Rochester, MN USALin, Yi论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Div Hematol, Rochester, MN USAPatel, Krina K.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Div Hematol, Rochester, MN USAKumar, Shaji论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Div Hematol, Rochester, MN USAHansen, Doris K.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Div Hematol, Rochester, MN USA
- [47] Bendamustine Lymphodepletion (LD) Prior to Idecabtagene Vicleucel (Ide-cel) Is Associated with Inferior Outcomes in Relapsed Refractory Multiple Myeloma (RRMM)BLOOD, 2023, 142Ravi, Gayathri论文数: 0 引用数: 0 h-index: 0机构: Univ Alabama Birmingham, Rochester, MN USA Univ Alabama Birmingham, Rochester, MN USABal, Susan论文数: 0 引用数: 0 h-index: 0机构: Univ Alabama Birmingham, Birmingham, AL USA Univ Alabama Birmingham, Rochester, MN USA论文数: 引用数: h-index:机构:论文数: 引用数: h-index:机构:Hebert, Courtney论文数: 0 引用数: 0 h-index: 0机构: Univ Alabama Birmingham, Birmingham, AL USA Univ Alabama Birmingham, Rochester, MN USAParekh, Binita论文数: 0 引用数: 0 h-index: 0机构: Univ Alabama Birmingham, Birmingham, AL USA Univ Alabama Birmingham, Rochester, MN USASteele, JoAnn论文数: 0 引用数: 0 h-index: 0机构: Univ Alabama Birmingham, Birmingham, AL USA Univ Alabama Birmingham, Rochester, MN USABrown, Jessica论文数: 0 引用数: 0 h-index: 0机构: Univ Alabama Birmingham, Birmingham, AL USA Univ Alabama Birmingham, Rochester, MN USALangley, Kathy论文数: 0 引用数: 0 h-index: 0机构: Univ Alabama Birmingham, Birmingham, AL USA Univ Alabama Birmingham, Rochester, MN USACosta, Luciano论文数: 0 引用数: 0 h-index: 0机构: Univ Alabama Birmingham, Birmingham, AL USA Univ Alabama Birmingham, Rochester, MN USA
- [48] Subsequent Anti-Myeloma Therapy after Idecabtagene Vicleucel (ide-cel, bb2121) Treatment in Patients with Relapsed/Refractory Multiple Myeloma from the KarMMa StudyBLOOD, 2021, 138Rodriguez-Otero, Paula论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra Clin, Pamplona, Spain Univ Navarra Clin, Pamplona, SpainSan-Miguel, Jesus F.论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra Clin, CIMA, CIBERONC, IDISNA, Pamplona, Spain Univ Navarra Clin, Pamplona, SpainAnderson, Larry D., Jr.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas SouthWestern, Dallas, TX USA Univ Navarra Clin, Pamplona, SpainLonial, Sagar论文数: 0 引用数: 0 h-index: 0机构: Emory Sch Med, Atlanta, GA USA Univ Navarra Clin, Pamplona, SpainTruppel-Hartmann, Anna论文数: 0 引用数: 0 h-index: 0机构: Bluebird bio, Cambridge, MA USA Univ Navarra Clin, Pamplona, SpainSanford, Jill论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Univ Navarra Clin, Pamplona, SpainRowe, Everton论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Univ Navarra Clin, Pamplona, SpainCampbell, Timothy B.论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Univ Navarra Clin, Pamplona, SpainMunshi, Nikhil C.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA USA Univ Navarra Clin, Pamplona, Spain
- [49] Idecabtagene Vicleucel Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma with Renal Insufficiency: Real World ExperienceBLOOD, 2022, 140 : 10377 - 10379Sidana, Surbhi论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Dept Med, Sch Med, Div Blood & Marrow Transplantat & Cellular Therap, Stanford, CA USA Stanford Univ, Dept Med, Sch Med, Div Blood & Marrow Transplantat & Cellular Therap, Stanford, CA USAPeres, Lauren C.论文数: 0 引用数: 0 h-index: 0机构: H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA Stanford Univ, Dept Med, Sch Med, Div Blood & Marrow Transplantat & Cellular Therap, Stanford, CA USAHashmi, Hamza论文数: 0 引用数: 0 h-index: 0机构: Med Univ South Carolina, Dept Hematol Med Oncol, Charleston, SC 29425 USA Stanford Univ, Dept Med, Sch Med, Div Blood & Marrow Transplantat & Cellular Therap, Stanford, CA USAHosoya, Hitomi论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Dept Med, Sch Med, Div Oncol, Stanford, CA USA Stanford Univ, Dept Med, Sch Med, Div Hematol, Stanford, CA USA Stanford Univ, Dept Med, Sch Med, Div Blood & Marrow Transplantat & Cellular Therap, Stanford, CA USAFerreri, Christopher J.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Stanford Univ, Dept Med, Sch Med, Div Blood & Marrow Transplantat & Cellular Therap, Stanford, CA USAAtrash, Shebli论文数: 0 引用数: 0 h-index: 0机构: Levine Canc Inst, Charlotte, NC USA Stanford Univ, Dept Med, Sch Med, Div Blood & Marrow Transplantat & Cellular Therap, Stanford, CA USAKhouri, Jack论文数: 0 引用数: 0 h-index: 0机构: Cleveland Clin, Dept Hematol & Med Oncol, Taussig Canc Inst, Cleveland, OH USA Stanford Univ, Dept Med, Sch Med, Div Blood & Marrow Transplantat & Cellular Therap, Stanford, CA USAVoorhees, Peter M.论文数: 0 引用数: 0 h-index: 0机构: Levine Canc Inst, Charlotte, NC USA Stanford Univ, Dept Med, Sch Med, Div Blood & Marrow Transplantat & Cellular Therap, Stanford, CA USADima, Danai论文数: 0 引用数: 0 h-index: 0机构: Cleveland Clin, Dept Translat Hematol & Oncol Res, Taussig Canc Inst, Cleveland, OH USA Stanford Univ, Dept Med, Sch Med, Div Blood & Marrow Transplantat & Cellular Therap, Stanford, CA USASimmons, Gary论文数: 0 引用数: 0 h-index: 0机构: Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA USA Stanford Univ, Dept Med, Sch Med, Div Blood & Marrow Transplantat & Cellular Therap, Stanford, CA USAKalariya, Nilesh论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Stanford Univ, Dept Med, Sch Med, Div Blood & Marrow Transplantat & Cellular Therap, Stanford, CA USAHovanky, Vanna论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Dept Med, Div Blood & Marrow Transplantat & Cellular Therap, Stanford, CA 94305 USA Stanford Univ, Dept Med, Sch Med, Div Blood & Marrow Transplantat & Cellular Therap, Stanford, CA USABharadwaj, Sushma论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Div BMT & Cellular Therapy, Stanford, CA USA Stanford Univ, Dept Med, Sch Med, Div Blood & Marrow Transplantat & Cellular Therap, Stanford, CA USAArai, Sally论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Div BMT & Cellular Therapy, Sch Med, Stanford, CA USA Stanford Univ, Dept Med, Sch Med, Div Blood & Marrow Transplantat & Cellular Therap, Stanford, CA USAMiklos, David B.论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Div BMT & Cellular Therapy, Stanford, CA USA Stanford Univ, Dept Med, Sch Med, Div Blood & Marrow Transplantat & Cellular Therap, Stanford, CA USAWagner, Charlotte B.论文数: 0 引用数: 0 h-index: 0机构: Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA Stanford Univ, Dept Med, Sch Med, Div Blood & Marrow Transplantat & Cellular Therap, Stanford, CA USA论文数: 引用数: h-index:机构:Sborov, Douglas W.论文数: 0 引用数: 0 h-index: 0机构: Univ Utah, Huntsman Canc Inst, Sch Med, Salt Lake City, UT USA Stanford Univ, Dept Med, Sch Med, Div Blood & Marrow Transplantat & Cellular Therap, Stanford, CA USANishihori, Taiga论文数: 0 引用数: 0 h-index: 0机构: H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplant & Cellular Immunot, Tampa, FL USA Stanford Univ, Dept Med, Sch Med, Div Blood & Marrow Transplantat & Cellular Therap, Stanford, CA USAAlsina, Melissa论文数: 0 引用数: 0 h-index: 0机构: H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA Stanford Univ, Dept Med, Sch Med, Div Blood & Marrow Transplantat & Cellular Therap, Stanford, CA USALocke, Frederick L.论文数: 0 引用数: 0 h-index: 0机构: H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplant & Cellular Immunot, Tampa, FL USA Stanford Univ, Dept Med, Sch Med, Div Blood & Marrow Transplantat & Cellular Therap, Stanford, CA USAGonzalez, Rebecca论文数: 0 引用数: 0 h-index: 0机构: H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplant & Cellular Immunot, Tampa, FL USA Stanford Univ, Dept Med, Sch Med, Div Blood & Marrow Transplantat & Cellular Therap, Stanford, CA USAKocoglu, M. Hakan论文数: 0 引用数: 0 h-index: 0机构: Univ Maryland, Greenebaum Comprehens Canc Ctr, Baltimore, MD USA Stanford Univ, Dept Med, Sch Med, Div Blood & Marrow Transplantat & Cellular Therap, Stanford, CA USASannareddy, Aishwarya论文数: 0 引用数: 0 h-index: 0机构: UT Southwestern Harold C Simmons Comprehens Canc, Div Hematol Malignancies, Dallas, TX USA Stanford Univ, Dept Med, Sch Med, Div Blood & Marrow Transplantat & Cellular Therap, Stanford, CA USAAfrough, Aimaz论文数: 0 引用数: 0 h-index: 0机构: UT Southwestern Med Ctr, Div Hematol Malignancies & Cellular Therapy, Dept Internal Med, Harold C Simmons Comprehens Canc Ctr, Dallas, TX USA Stanford Univ, Dept Med, Sch Med, Div Blood & Marrow Transplantat & Cellular Therap, Stanford, CA USAMcGuirk, Joseph P.论文数: 0 引用数: 0 h-index: 0机构: Univ Kansas, Med Ctr, Kansas City, KS 66103 USA Stanford Univ, Dept Med, Sch Med, Div Blood & Marrow Transplantat & Cellular Therap, Stanford, CA USAShune, Leyla O.论文数: 0 引用数: 0 h-index: 0机构: Univ Kansas, Med Ctr, Kansas City, KS 66103 USA Stanford Univ, Dept Med, Sch Med, Div Blood & Marrow Transplantat & Cellular Therap, Stanford, CA USAPatel, Krina论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Stanford Univ, Dept Med, Sch Med, Div Blood & Marrow Transplantat & Cellular Therap, Stanford, CA USAHansen, Doris K.论文数: 0 引用数: 0 h-index: 0机构: H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplant & Cellular Immunot, Tampa, FL USA Stanford Univ, Dept Med, Sch Med, Div Blood & Marrow Transplantat & Cellular Therap, Stanford, CA USA
- [50] Characterization of Cytokine Release Syndrome in the KarMMa Study of Idecabtagene Vicleucel (ide-cel, bb2121) for Relapsed and Refractory Multiple MyelomaBLOOD, 2020, 136Kansagra, Ankit论文数: 0 引用数: 0 h-index: 0Lin, Yi论文数: 0 引用数: 0 h-index: 0Berdeja, Jesus G.论文数: 0 引用数: 0 h-index: 0Shah, Nina论文数: 0 引用数: 0 h-index: 0Oriol, Albert论文数: 0 引用数: 0 h-index: 0Yakoub-Agha, Ibrahim论文数: 0 引用数: 0 h-index: 0Einsele, Hermann论文数: 0 引用数: 0 h-index: 0Rambaldi, Alessandro论文数: 0 引用数: 0 h-index: 0Truppel-Hartmann, Anna论文数: 0 引用数: 0 h-index: 0Rowe, Everton论文数: 0 引用数: 0 h-index: 0Wang, Julie论文数: 0 引用数: 0 h-index: 0Agarwal, Amit论文数: 0 引用数: 0 h-index: 0Campbell, Timothy B.论文数: 0 引用数: 0 h-index: 0Lonial, Sagar论文数: 0 引用数: 0 h-index: 0